Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Partnering

October 22, 2021 Events

PODD: Partnerships in Drug Delivery

PODD: Partnerships in Drug Delivery is offered as a hybrid program with a virtual option held on October 28-29, 2021.

Continue reading

October 20, 2021 Events / Pharma applications

AusBiotech 2021

AusBiotech is the leading Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy.

Continue reading

October 8, 2021 Events / Pharma applications

BioJapan

BioJapan is Asia’s premier hyrid partnering event held on October 13–15, 2021 in Yokohama, Japan. This event is consituted by

Continue reading

February 26, 2021 Events

BIO-Europe Spring® Digital

BIO-Europe Spring® Digital for biopharmas will be held on March 22-25, 2021. This year’s digital event will include on-demand early

Continue reading

September 11, 2020 Events / Pharma applications

BIO Investor Forum – Digital Oct. 13-15, 2020

BIO Investor Forum Digital: The industry’s leading biopharma executives and BD professionals from public and venture-stage growth companies, and top

Continue reading

June 19, 2020 CD as API / CD derivatives / Pharma applications

Underdog Pharmaceuticals Announces MD.USE Partnership and Technology Acquisition

Underdog Pharmaceuticals, Inc., a pharmaceutical company designing engineered cyclodextrins to address atherosclerosis and other serious diseases of aging, has completed

Continue reading

March 11, 2019 Events / Pharma applications

BIO-EUROPE SPRING

The 13th Annual International Partnering Conference BIO-EUROPE SPRING will be held on March 25–27, 2019 in Vienna, Austria. The following

Continue reading

Recent Posts

  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (443)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (832)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,241)
  • Supramolecular systems (45)
  • Uncategorized (176)

Top Posts

  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Enantioseparation and molecular docking study of selected chiral pharmaceuticals on a commercialized phenylcarbamate-β-cyclodextrin column using polar organic mode

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...